Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...

A judge in Texas, where abortion is banned, could block mifepristone for the entire country. The case has the potential to change all drug regulation in the US.

AAPLOG Vice Chair Dr. Susan Bane discusses the potential health risks of abortion drugs like mifepristone on ‘Fox & Friends ...

On behalf of the Ethics and Public Policy Center (where I work), I have submitted an amicus brief in FDA v. Alliance for Hippocratic Medicine, which will be argued in the Supreme Court on March 26.

Nothing in the statute requires FDA to address in those decisions other laws that may restrict the drug’s distribution or use. Instead, the FDCA properly leaves enforcement of those laws to the ...

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

Food and Drug Administration Commissioner Martin Makary confirmed in a Monday letter to the Missouri senator that the agency will conduct a safety review of the abortion pill mifepristone.Makary ...

The Food and Drug Administration said Thursday that it would permanently remove a key restriction on medication used to terminate pregnancies, allowing so-called "abortion pills" to be available ...

By questioning the FDA's authority to regulate an abortion drug, ... said the ruling "subjects the FDA decision making in this case to a very detailed scrutiny and second guesses FDA review of ...

The FDA’s original drug approval in 2000 could stand, the panel said, but the later modifications to how the drug could be prescribed and at what point in a pregnancy would be tossed. Advertisement ...

The Biden administration is removing a requirement that one of the drugs involved in medication abortion be dispensed in person during the Covid-19 pandemic.

Republican Sen. Josh Hawley’s quest to legitimize a junk science report undermining the safety of a widely used abortion pill was fully realized this week. “As with all drugs, FDA continues to ...